Priority Research Programme
Healthy Digestion (HD) Foods for Improving Gut Comfort
Professor Nicole Roy
Dr Nicole Roy is a Professor in the Liggins Institute at the University of Auckland. She is based in Palmerston North and leads the Digestive Health priority research programme for the High-Value Nutrition National Science Challenge. Nicole completed her PhD in Canada and the United States and post doctoral studies in Scotland where she focused on how nutrition and food components can modify inter-organ nutrient partitioning and communication using tracer kinetics, animal models and in vitro models. She is also an Adjunct Professor at the Riddet Institute.
|Prof Richard Gearry||University of Otago, Canterbury District Health Board||https://orcid.org/0000-0002-2298-5141|
|Dr Karl Fraser||AgResearch Limited||https://orcid.org/0000-0002-1136-4024|
|Dr Wayne Young||AgResearch Limited||https://orcid.org/0000-0003-0464-2062|
|Dr Janine Cooney||Plant and Food Research||https://orcid.org/0000-0002-2547-0100|
|Dr Olivier Gasser||Malaghan Institute||https://orcid.org/0000-0002-8235-2274|
|Prof Warren McNabb||Riddet Institute||https://orcid.org/0000-0003-2514-6551|
|Dr Tim Angeli||University of Auckland||https://orcid.org/0000-0003-1610-3787|
|Dr Amber Milan||University of Auckland||https://orcid.org/0000-0002-9559-7326|
|Dr Eric Altermann||AgResearch Limited||https://orcid.org/0000-0003-1376-1549|
|Dr Jane Mullaney||AgResearch Limited||https://orcid.org/0000-0002-4910-7605|
|Dr Meika Foster||Edible Research Ltd||https://orcid.org/0000-0002-3828-0840|
|Dr Matthew Barnett||AgResearch Limited||https://orcid.org/0000-0002-5186-5579|
|Dr Jacqui Keenan||University of Otago||http://orcid.org/0000-0002-3409-0337|
|Dr Paula Skidmore||University of Otago||https://orcid.org/0000-0002-6628-4523|
|Prof Paul Cotter||Teagasc Food Research Centre||https://orcid.org/0000-0002-5465-9068|
Principal Investigator: Professor Nicole Roy, Liggins Institute, University of Auckland
Collaborating Organisations: AgResearch Limited, Malaghan Institute, University of Otago, Plant and Food Research
In New Zealand’s large and growing food export markets in Asia we know that digestive health is a common and rising topic of concern. Healthy digestion is critical to physical health, and mental health and well-being. Approximately 30% of the population has at least one of the functional gastrointestinal disorders where “everything looks normal” and there is no detectable disease, but there are abnormal digestive processes such as altered transit and hypersensitivity. The mechanisms underpinning these health parameters are poorly defined.
Our research programme focuses on New Zealand’s food and beverage products for improving gastrointestinal function and comfort. We seek to understand the linkages between diet, gastrointestinal symptoms and disorders, metabolism, physiology and microbial populations (the microbiome) to better predict food-health gastrointestinal relationships. This will enable the New Zealand’s food and beverage industry to predict the gastrointestinal health benefits of foods and ingredients and generate validated scientific evidence of these health benefits.
Our understanding of the linkages between diet, gastrointestinal symptoms, metabolism, physiology and the microbiome has been enabled by the establishment of a patient cohort, named COMFORT, and a database of information relating to the cohort. This has involved the development of a world-first validated questionnaire, the Food and Symptom Times diary which addresses a knowledge gap by enabling the food consumed on a given day to be linked with gastrointestinal symptoms. Other validated questionnaires addressing gastrointestinal symptoms, anxiety and depression symptoms and quality of life were used to cluster the participants recruited into the COMFORT cohort: healthy controls and those with constipation or diarrhoea, including individuals with irritable bowel syndrome. International collaborations have enabled world-leading methods to be used for the analysis of a comprehensive suite of metabolites present in plasma, urine and breath samples obtained from the participants.
Our analyses have highlighted differences between COMFORT participants and healthy symptom-free control participants. We have seen perturbations in amino acid and lipid metabolism that are known to be associated with gastrointestinal dysfunction. Analysis of the microbiome genetic information in faecal samples has shown potential microbial mechanisms that distinguish between participants with functional gastrointestinal disorders and healthy participants. These results provide an important first step in understanding how the gastrointestinal microbiome impacts human health when gastrointestinal function is suboptimal. Our approach has enabled greater knowledge on microbiome composition and function than other studies, and we now have strong evidence that we can cluster these disorders based on metabolic and microbial biomarkers.
The research team is multidisciplinary, comprising leading New Zealand’s researchers who collaborate internationally and present their research to the global research community. International world-leading researchers in the gastrointestinal field recognise the Healthy Digestion programme as unique in its approach and scale, having the potential to generate significant health and industry outcomes.
The research team includes a Māori researcher affiliated to Ngāti Porou and Ngāti Raukawa, who is progressing Māori science leadership opportunities and capability in the integration of high-dimensional biological data with clinical data. We are committed to strengthening Māori researcher capacity and capability within our programme as we progress our research.
The Healthy Digestion programme works closely with the New Zealand’s food and beverage industry, including Māori agribusinesses, to ensure our research is relevant for industry. This includes work with New Zealand’s industry partners to validate our approach and test food concepts. We will continue to assist Māori and non-Māori food and beverage entities, in developing and testing novel foods for improved gastrointestinal health outcomes. The programme supports the mission of the High-Value Nutrition Challenge to generate knowledge and capability that the New Zealand’s food and beverage industry can utilise to develop high-value foods with validated health outcomes and thus increase export revenues.
Fraser, K., W. Young, W. McNabb, R. Gearry & N. Roy. (2019). Lipid and metabolite profiles in human plasma and associations with the microbiome and functional gastrointestinal disorders (P20-033-19). Current Developments in Nutrition. 3(1). https://doi.org/10.1093/cdn/nzz040.P20-033-19
James, C., K. Fraser, W. Young, W. McNabb, R. Gearry & N. Roy. (2019). Understanding how metabolites link diet, host, and microbiota in a dysfunctional gut model is important to establishing a system-wide understanding of gut function (P20-035-19). Current Developments in Nutrition. 3(1). https://doi.org/10.1093/cdn/nzz040.P20-035-19
Kortlever TL, Ten Bokkel Huinink S, Offereins M, Hebblethwaite C, O’Brien L, Leeper J, Mulder CJJ, Barrett JS, Gearry RB. (2019). Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study. Nutr Clin Pract. https://doi.org/10.1002/ncp.10233
Mullaney JA, Stephens JE, Geeling BE & Hamilton-Williams EE. (2019). Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice. Immunology and Cell Biology. https://doi.org/10.1111/imcb.12201
Young, W., C. Carco, J. Mullaney, P. Maclean, P. Cotter, K. Fraser, W. McNabb, R. Gearry & N. Roy. (2019). The microbiome in functional gastrointestinal disorders is characterized by bacteria and genes involved in carbohydrate and bile acid metabolism (OR23-01-19). Current Developments in Nutrition. 3(1). https://doi.org/10.1093/cdn/nzz040.OR23-01-19
Aidoud, N., Delplanque, B., Baudry, C., Garcia, C., Moyon, A., Balasse, L., Guillet, B., Antona, C., Darmaun, D., Fraser, K., Ndiaye, S., Leruyet, P. & Martin, J.C. (2018). A combination of lipidomics, MS imaging, and PET scan imaging reveals differences in cerebral activity in rat pups according to the lipid quality of infant formulas. FASEB Journal. 32(9). https://doi.org/10.1096/fj.201800034R
Gavin, PG., Mullaney, JA., Loo, D., Lê Cao, K-A., Gottlieb, PA, Hill, MM., Zipris, D. & Hamilton-Williams, EE. (2018). Intestinal metaproteomics reveals host-microbiota interactions in subjects at risk for type 1 diabetes. Diabetes Care. 41(10): 2178-2186. https://doi.org/10.2337/dc18-0777.
Laing, B., Barnett, MPG., Marlow, G., Nasef, NA. & Ferguson, LR. (2018). An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets. Expert Review of Gastroenterology and Hepatology. 12(10): 969-983. https://doi.org/10.1080/17474124.2018.1505497.
McCann, M.J., Rotjanapun, K., Hesketh, J.E. & Roy, N.C. (2018). Expression profiling indicating low selenium-sensitive microRNA levels linked to cell cycle and cell stress response pathways in the CaCo-2 cell line. British Journal of Nutrition. 117(9):1212-1221. https://doi.org/10.1017/S0007114517001143
Mullaney, J.A., Stephens, J.E., Costello, M.E., Fong, C., Geeling, B.E.; Gavin, P.G., Wright, C.M., Spector, T.D., Brown, M.A. & Hamilton-Williams, E.E. (2018). Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota. Microbiome. 6(1):51. https://doi.org/10.1186/s40168-018-0438-z
Riedle, S., Pele, L.C., Otter, D.E., Hewitt, R.E., Singh, H., Roy, N.C. & Powell, J.J. (2018). Pro-inflammatory adjuvant properties of pigment-grade titanium dioxide are augmented by an ‘at-risk’-genotype that potentiates interleukin 1β processing. Particle and Fibre Toxicology. 14(1):51. https://doi.org/10.1186/s12989-017-0232-2
Digestive Health highlights
Innovative product using seaweed waste and greenshell mussels to be developed for anti-inflammatory effects
The GreenshellTM mussel (GSM) Perna canaliculus is an iconic New Zealand seafood product that is highly valued by consumers in New Zealand and overseas for its unique flavour and visual appeal, and increasingly for its anti-inflammatory properties. Funded by the...
MIHI (Movers in Hemp Innovation) is a collaboration of Māori and non-Māori entities seeking to grow the hemp industry in New Zealand. The MIHI business cluster has received a $100,000 Māori Food & Beverage Development Grant from the High-Value Nutrition (HVN)...
In praise of the mussel and foods from the shoreline…and the Cawthron Institute – a powerhouse of New Zealand science and innovation
By Richard Mithen, High-Value Nutrition National Science Challenge Chief Scientist One of the great privileges of my job as Chief Scientist of HVN is having the opportunity to visit the many centres of science excellence in New Zealand. It was a particular pleasure to...